Consumption of melatonin supplement improves cardiovascular disease risk factors and anthropometric indices in type 2 diabetes mellitus patients: a double-blind, randomized, placebo-controlled trial

Documenti analoghi

• Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled Trial
  di: Zare Javid, Ahmad, et al.
  Pubblicazione: (2020)
• The Impacts of Synbiotic Supplementation on Periodontal Indices and Biomarkers of Oxidative Stress in Type 2 Diabetes Mellitus Patients with Chronic Periodontitis Under Non-Surgical Periodontal Therapy. A Double-Blind, Placebo-Controlled Trial
  di: Bazyar, Hadi, et al.
  Pubblicazione: (2020)
• The effects of ginger supplementation on inflammatory, antioxidant, and periodontal parameters in type 2 diabetes mellitus patients with chronic periodontitis under non-surgical periodontal therapy. A double-blind, placebo-controlled trial
  di: Zare Javid, Ahmad, et al.
  Pubblicazione: (2019)
• Effects of Concurrent Omega-3 and Cranberry Juice Consumption Along with Standard Antibiotic Therapy on the Eradication of Helicobacter pylori, Gastrointestinal Symptoms, Some Serum Inflammatory and Oxidative Stress Markers in Adults with Helicobacter pylori Infection: A Study Protocol for a Randomized Controlled Trial
  di: Zare Javid, Ahmad, et al.
  Pubblicazione: (2020)
• Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study
  di: Montes, Luis G. Almeida, et al.
  Pubblicazione: (2003)